Wizol

Wizol may be available in the countries listed below.

Ingredient matches for Wizol

Ketoconazole

Ketoconazole is reported as an ingredient of Wizol in the following countries:

• Indonesia

International Drug Name Search

Larimef

Larimef may be available in the countries listed below.

Ingredient matches for Larimef

Mefloquine

Mefloquine hydrochloride (a derivative of Mefloquine) is reported as an ingredient of Larimef in the following countries:

• Myanmar

International Drug Name Search

Calcijex

Calcijex is a brand name of calcitriol, approved by the FDA in the following formulation(s):

CALCIJEX (calcitriol - injectable; injection)

• 
  Manufacturer: ABBOTT
  
  Approval date: September 25, 1986
  
  Strength(s): 0.001MG/ML ^[RLD][AP], 0.002MG/ML ^[RLD][AP]

Has a generic version of Calcijex been approved?

A generic version of Calcijex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Calcijex and have been approved by the FDA:

calcitriol injectable; injection

• 
  Manufacturer: AKORN
  
  Approval date: January 29, 2008
  
  Strength(s): 0.001MG/ML ^[AP], 0.002MG/ML ^[AP]


• 
  Manufacturer: APP PHARMS
  
  Approval date: December 31, 2002
  
  Strength(s): 0.001MG/ML ^[AP], 0.002MG/ML ^[AP]


• 
  Manufacturer: FRESENIUS MEDCL
  
  Approval date: February 20, 2003
  
  Strength(s): 0.001MG/ML ^[AP], 0.002MG/ML ^[AP]


• 
  Manufacturer: LUITPOLD
  
  Approval date: September 26, 2003
  
  Strength(s): 0.001MG/ML ^[AP], 0.002MG/ML ^[AP]


• 
  Manufacturer: ROCKWELL MEDCL
  
  Approval date: September 17, 2003
  
  Strength(s): 0.001MG/ML ^[AP]


• 
  Manufacturer: SAGENT PHARMS
  
  Approval date: February 8, 2006
  
  Strength(s): 0.001MG/ML ^[AP]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: March 31, 2003
  
  Strength(s): 0.002MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Calcijex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Low oxygen content compositions of 1.alpha., 25-dihydroxycholecalciferol
  Patent 6,051,567
  Issued: April 18, 2000
  Inventor(s): Abrahamson; Kent & Anderson; Amy N. & Grady; Haiyan
  Assignee(s): Abbott Laboratories
  The invention relates to stable aqueous formulations comprising 1.alpha., 25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them.
  
  Patent expiration dates:
  
  
  • August 2, 2019
    
  
  
  
  • February 2, 2020
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Low oxygen content compositions of 1.alpha., 25-dihydroxycholeclciferol
  Patent 6,265,392
  Issued: July 24, 2001
  Inventor(s): Abrahamson; Kent & Anderson; Amy N. & Grady; Haiyan
  Assignee(s): Abbott Laboratories
  The invention relates to stable aqueous formulations comprising 1.alpha.,25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them.
  
  Patent expiration dates:
  
  
  • August 2, 2019
    
  
  
  
  • February 2, 2020
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Low oxygen content compostions of 1.alpha., 25-dihydroxycholecalciferol
  Patent 6,274,169
  Issued: August 14, 2001
  Inventor(s): Abrahamson; Kent & Anderson; Amy N. & Grady; Haiyan & Hartmann; Kurt J. & Farmer; Randall M. & Oberdier; John P.
  Assignee(s): Abbott Laboratories
  The invention relates to stable compositions comprising 1.alpha., 25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them.
  
  Patent expiration dates:
  
  
  • August 2, 2019
    
  
  
  
  • February 2, 2020
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Calcijex Solution Consumer Information (Wolters Kluwer)
• Calcitriol Consumer Information (Wolters Kluwer)
• Calcitriol Solution Consumer Information (Wolters Kluwer)
• Calcitriol Consumer Information (Cerner Multum)
• Calcitriol AHFS DI Monographs (ASHP)

Chol-Spasmoletten

Chol-Spasmoletten may be available in the countries listed below.

Ingredient matches for Chol-Spasmoletten

Hymecromone

Hymecromone is reported as an ingredient of Chol-Spasmoletten in the following countries:

• Germany

International Drug Name Search

Cilate

Cilate may be available in the countries listed below.

Ingredient matches for Cilate

Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Cilate in the following countries:

• South Africa

International Drug Name Search

Nilandron

Nilandron is a brand name of nilutamide, approved by the FDA in the following formulation(s):

NILANDRON (nilutamide - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: April 30, 1999
  
  Strength(s): 150MG ^[RLD]

Has a generic version of Nilandron been approved?

No. There is currently no therapeutically equivalent version of Nilandron available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nilandron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Nilandron.

See also...

• Nilandron Consumer Information (Wolters Kluwer)
• Nilandron Consumer Information (Cerner Multum)
• Nilandron Advanced Consumer Information (Micromedex)
• Nilandron AHFS DI Monographs (ASHP)
• Nilutamide Consumer Information (Wolters Kluwer)
• Nilutamide Consumer Information (Cerner Multum)
• Nilutamide Advanced Consumer Information (Micromedex)
• Nilutamide AHFS DI Monographs (ASHP)

Uriflox

Uriflox may be available in the countries listed below.

Ingredient matches for Uriflox

Norfloxacin

Norfloxacin is reported as an ingredient of Uriflox in the following countries:

• Ethiopia

International Drug Name Search